Fluidnatek successfully participated in MEDICA-COMPAMED 2025, the leading international event for the healthcare industry, which brought together over 5,300 exhibitors from 70 nations and attracted 78,000 professional visitors from November 17 to 20 in Düsseldorf. This participation provided a valuable opportunity to connect with the international scientific community and gain deeper insights into the trends shaping the future of biomedical applications.
A Strategic Encounter with the Global Healthcare Ecosystem
From Stand 8bK34 in Hall 8B at COMPAMED, our team conducted live demonstrations of the LE-50 Gen2 system throughout all four days of the fair, allowing visitors to experience firsthand the capabilities of electrospinning technology and establish meaningful connections with top-level professionals in the sector. The fair, which adopted the theme “Meet Health. Future. People.” this year, consolidated its position as an essential meeting point for healthcare industry decision-makers. According to the organizers’ data, three-quarters of professional visitors belong to senior management at their companies or organizations, and 75% traveled from 160 different countries, confirming the truly global reach of the event.
The intensive days in Düsseldorf proved particularly enriching for Fluidnatek. The dynamic exchanges with visitors from different regions around the world provided valuable perspectives on current challenges in the biomedical sector and emerging needs in areas such as tissue engineering, regenerative medicine, and advanced drug delivery systems.
Key Learnings for Future Development
Participation in MEDICA-COMPAMED 2025 enabled Fluidnatek to identify important trends that will guide our technological development in the coming years:
Tissue Regeneration and Personalized Medicine: Conversations with researchers and clinical professionals revealed a growing demand for more versatile solutions for creating 2D and 3D scaffolds tailored to specific applications, from bone and cartilage regeneration to vascular engineering.
Advanced Wound Healing: The interest shown in next-generation wound dressings with superior healing properties underscores the need to continue innovating in functional materials that integrate antimicrobial capabilities, growth factors, and controlled release of active ingredients.
Smart Medical Devices: The integration of specialized coatings in medical devices with complex geometries emerges as a high-potential area, particularly in implants and devices with prolonged tissue contact.
Controlled Release Platforms: The development of drug delivery systems based on functionalized nanofibers remains a field of great interest, particularly in oncology, chronic disease treatment, and localized therapies.
Strategic Collaborations and Industry Synergies
One of the most valuable aspects of participating in COMPAMED has been the opportunity to establish dialogues with leading companies in the sector.
This environment has allowed Fluidnatek to position itself as a technology partner specializing in electrospinning and electrospraying processes, with capabilities ranging from biomedical research to applications in pharmacy, cosmetics, filtration, energy, and new materials.
Looking Toward the Future of Biomedicine
The experience at MEDICA-COMPAMED 2025 reinforces Fluidnatek’s vision of the transformative role that nanofiber technologies can play in the medicine of the future. The conversations held during the fair provided valuable insights into the directions in which the biomedical sector is evolving:
- The growing demand for solutions for organoids and complex tissue models that enable advances in personalized medicine and more predictive preclinical trials.
- Interest in sterile applications and systems that ensure maximum safety for implants and devices in direct contact with the organism.
- The need for scalability and reproducibility in the manufacturing of advanced biomedical materials.
- The integration of multiple functionalities into a single technological platform, combining mechanical, biological, and pharmacological properties.
Becky Thunio and Enrique Navarro at the Fluidnatek booth during COMPAMED 2025.
Ongoing Commitment to Innovation
The next edition of MEDICA and COMPAMED will take place from November 16 to 19, 2026, in Düsseldorf. The organizers have announced they will continue developing both events toward greater integration, leveraging synergies and expanding their international relevance, with the goal of facilitating even more intensive interdisciplinary dialogue among industry, science, politics, and clinical practice.
For Fluidnatek, participation in MEDICA-COMPAMED is not simply an exhibition opportunity, but an ongoing commitment to learning, collaborative innovation, and developing solutions that respond to the real needs of the biomedical sector. The knowledge acquired at this edition will guide our R&D efforts and allow us to remain a reference in electrospinning technologies for the advancement of biomedical applications.
We thank all the professionals who visited our stand and shared their experiences and visions about the future of biomedicine. These exchanges are fundamental to continuing the development of technologies that truly make a difference in people’s health and well-being.
ESP